ALLMedicine™ Type 2 Diabetes Center

Oct 21st, 2020 - To determine whether the benefits of dapagliflozin in patients with heart failure and reduced ejection fraction (HFrEF) and type 2 diabetes in the Dapagliflozin And Prevention of Adverse-Outcomes in Heart Failure trial (DAPA-HF) varied by backgrou...

Oct 21st, 2020 - This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and th...

Oct 21st, 2020 - Some studies have suggested that daytime napping may increase the risk of type 2 diabetes. However, limited data have revealed the association between nap duration and other metabolic diseases. Data from the baseline survey of Lanxi Cohort Study, ...

Oct 21st, 2020 - Glycated haemoglobin (HbA1c) is considered the gold standard for predicting glycaemia-associated risks for the microvascular and macrovascular complications of diabetes mellitus over 5-10 years. The value of HbA1c in the care of patients with type...

Oct 21st, 2020 - Diabetic nephropathy is a common and serious complication of diabetes mellitus (DM) and is one of the leading causes of end-stage renal disease worldwide. Although there have been many investigations on biomarkers for DN, there is no consistent co...

Oct 13th, 2020 - Gestational diabetes (GDM) is a common metabolic complication of pregnancy that is generally asymptomatic in its clinical course, although it is potentially associated with a wide range of both maternal and foetal complications. The population pre...

Oct 11th, 2020 - Type 2 diabetes and climate change are forefront global challenges of the 21st century. Both are on a progressive incline with intergenerational effects on the wellbeing, health and security of the population. The aim of this review was to explore...

Sep 16th, 2020 - A recent network meta-analysis of 450 randomized clinical trials demonstrated various benefits of some newer pharmacologic diabetes agents (NEJM JW Gen Med Aug 1 2020 and Ann Intern Med 2020; 173:278). Based on these and other data, the ADA recent...

Aug 10th, 2020 - 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.|2020|Das SR,Everett BM,Birtcher KK,Brown...

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

Oct 21st, 2020 - To determine whether the benefits of dapagliflozin in patients with heart failure and reduced ejection fraction (HFrEF) and type 2 diabetes in the Dapagliflozin And Prevention of Adverse-Outcomes in Heart Failure trial (DAPA-HF) varied by backgrou...

Oct 21st, 2020 - This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and th...

Oct 21st, 2020 - Some studies have suggested that daytime napping may increase the risk of type 2 diabetes. However, limited data have revealed the association between nap duration and other metabolic diseases. Data from the baseline survey of Lanxi Cohort Study, ...

Oct 21st, 2020 - Glycated haemoglobin (HbA1c) is considered the gold standard for predicting glycaemia-associated risks for the microvascular and macrovascular complications of diabetes mellitus over 5-10 years. The value of HbA1c in the care of patients with type...

Oct 21st, 2020 - Diabetic nephropathy is a common and serious complication of diabetes mellitus (DM) and is one of the leading causes of end-stage renal disease worldwide. Although there have been many investigations on biomarkers for DN, there is no consistent co...

Sep 16th, 2020 - A recent network meta-analysis of 450 randomized clinical trials demonstrated various benefits of some newer pharmacologic diabetes agents (NEJM JW Gen Med Aug 1 2020 and Ann Intern Med 2020; 173:278). Based on these and other data, the ADA recent...

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

Mar 23rd, 2020 - PHOENIX – Lower baseline fitness and greater decline in fitness over time are independently associated with a higher risk of heart failure in patients with diabetes, results from a large analysis showed. Doug Brunk/MDedge News Dr.

Mar 18th, 2020 - The Food and Drug Administration has approved safety labeling changes to all sodium-glucose transporter 2 (SGLT2) inhibitors used to treat high blood sugar in patients with type 2 diabetes. The new changes affect canagliflozin, dapagliflozin, empa.

Mar 18th, 2020 - Patients with both type 2 diabetes and asthma who were on glucagonlike peptide receptor–1 (GLP-1R) agonists for glucose control had lower levels of a key biomarker of airway inflammation than similar patients on other types of glucose-control medi.